D-Pharm Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

D-Pharm General Information

Description

Univo Pharmaceuticals Ltd is engaged in designing & developing drugs for the treatment of brain disorders. The company provides cannabis-based products for distribution and export to the international markets.

Contact Information

Website
www.dpharm.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Kiryat Weizmann Science Park
  • Building 7
  • Rehovot 76123
  • Israel
Primary Industry
Therapeutic Devices
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • Kiryat Weizmann Science Park
  • Building 7
  • Rehovot 76123
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

D-Pharm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 28-Mar-2018 Completed Generating Revenue
7. PIPE 22-Jan-2015 Completed Generating Revenue
6. IPO 17-Aug-2009 Completed Generating Revenue
5. Later Stage VC 07-Jul-2009 Completed Generating Revenue
4. Later Stage VC 14-May-2006 Completed Generating Revenue
3. Later Stage VC (Series AA) 30-Sep-2001 Completed Generating Revenue
2. Early Stage VC 03-Apr-1997 $6M $8M Completed Startup
1. Early Stage VC 01-Jan-1995 $2M $2M Completed Startup
To view D-Pharm’s complete valuation and funding history, request access »

D-Pharm Patents

D-Pharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2015092788-A1 Compositions comprising lipophilic diesters of chelating agents non-covalently associated with organic amines Inactive 17-Dec-2013
WO-2015092789-A1 Onium salts of lipophilic diesters of chelating agents Inactive 17-Dec-2013
WO-2011086561-A1 Process for the preparation of 3-(1-cyclopropenyl) propionic acid and its salts Inactive 17-Jan-2010
AU-2008278568-A1 Peptides derived from plasminogen activator inhibitor-1 and uses thereof Active 24-Jul-2007
AU-2008278568-B2 Peptides derived from plasminogen activator inhibitor-1 and uses thereof Inactive 24-Jul-2007 C07K14/8132
To view D-Pharm’s complete patent history, request access »

D-Pharm Former Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Apax Partners PE/Buyout Minority
Care Capital Venture Capital Minority
Clal Biotechnology Industries Venture Capital Minority
Denali Ventures Venture Capital Minority
Gemini Israel Ventures Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

D-Pharm Acquisitions (1)

D-Pharm’s most recent deal was a Merger/Acquisition with Thrombotech. The deal was made on 24-Jul-2012.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Thrombotech 24-Jul-2012 Merger/Acquisition Drug Discovery
To view D-Pharm’s complete acquisitions history, request access »

D-Pharm Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Thrombotech Ness Ziona, Israel 2000

D-Pharm FAQs

  • When was D-Pharm founded?

    D-Pharm was founded in 1993.

  • Where is D-Pharm headquartered?

    D-Pharm is headquartered in Rehovot, Israel.

  • What industry is D-Pharm in?

    D-Pharm’s primary industry is Therapeutic Devices.

  • Is D-Pharm a private or public company?

    D-Pharm is a Private company.

  • What is D-Pharm’s current revenue?

    The current revenue for D-Pharm is .

  • How much funding has D-Pharm raised over time?

    D-Pharm has raised $71.7M.

  • Who are D-Pharm’s investors?

    Apax Partners, Care Capital, Clal Biotechnology Industries, Denali Ventures, and Gemini Israel Ventures are 5 of 16 investors who have invested in D-Pharm.

  • When was D-Pharm acquired?

    D-Pharm was acquired on 28-Mar-2018.

  • Who acquired D-Pharm?

    D-Pharm was acquired by UNV Medicine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process